Advanced search
Publication Cover
Leukemia & Lymphoma Volume 57, 2016 - Issue 12
Submit an article Journal homepage
251
Views
5
CrossRef citations to date
0
Altmetric
Letter to the Editor

Response of relapsed central nervous system hairy cell leukemia to vemurafenib

Michael M. McDowellDepartment of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, USA;
,
Xiao ZhuDepartment of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, USA;
,
Nitin AgarwalDepartment of Neurological Surgery, University of Pittsburgh, Pittsburgh, PA, USA;
,
Marina N. NikiforovaDivision of Molecular and Genomic Pathology, University of Pittsburgh, Pittsburgh, PA, USA;
,
Frank S. LiebermanDivision of Neuro-Oncology, Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA
&
Jan DrappatzDivision of Neuro-Oncology, Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USACorrespondence[email protected]
Pages 2952-2954 | Received 06 Mar 2016, Accepted 08 Apr 2016, Published online: 27 Apr 2016

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Mark B. Geyer, Omar Abdel-Wahab & Martin S. Tallman. (2019) BRAF in the cross-hairs. Expert Review of Hematology 12:3, pages 183-193.
Read now

Articles from other publishers (4)

Anna E. Johnson, Athul Raj Raju, Aasems Jacob & Gerhard C. Hildebrandt. (2023) Case report: A case of classic hairy cell leukemia with CNS involvement treated with vemurafenib. Frontiers in Oncology 12.
Crossref
Jacqueline M Cortazar, Daniel J DeAngelo, Geraldine S Pinkus & Elizabeth A Morgan. (2017) Morphological and immunophenotypical features of hairy cell leukaemia involving lymph nodes and extranodal tissues. Histopathology 71:1, pages 112-124.
Crossref
Anamarija M. Perry, Kant Matsuda, Vikram WadhwaDonna Hewitt, Muhamad Almiski, James B. JohnstonVersha Banerji. (2017) Multifocal brain involvement in a patient with hairy cell leukemia successfully treated with rituximab and cladribine. Blood Advances 1:14, pages 899-902.
Crossref
. (2016) Vemurafenib. Reactions Weekly 1630:1, pages 246-246.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.